Clearwater Capital Advisors’s Compugen CGEN Stock Holding History

Clearwater Capital Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,905	Closed	-$23.6K	–	159
2023 Q4	$23.6K	Hold	11,905	–	–	﹤0.01%	154
2023 Q3	$11.1K	Sell	11,905 -1,071	-8%	-$1.18K	﹤0.01%	141
2023 Q2	$14.8K	Hold	12,976	–	–	﹤0.01%	148
2023 Q1	$9.11K	Hold	12,976	–	–	﹤0.01%	152
2022 Q4	$9.29K	Sell	12,976 -2,000	-13%	-$1.75K	﹤0.01%	159
2022 Q3	$10K	Hold	14,976	–	–	﹤0.01%	155
2022 Q2	$28K	Hold	14,976	–	–	﹤0.01%	149
2022 Q1	$48K	Buy	14,976 +1,200	+9%	+$4.05K	0.01%	168
2021 Q4	$59K	Buy	+13,776	New	+$74.5K	0.01%	167

Other funds holding CGEN

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Clearwater Capital Advisors's CGEN Position: Q1 2024 in Review

Clearwater Capital Advisors sold out of Compugen (CGEN) in Q1 2024, closing a stake of 11,905 shares — an estimated $23.6K sold.

Clearwater Capital Advisors first reported a position in CGEN in Q4 2021 and held it in 9 quarters. The position peaked at $59K in Q4 2021. 73 funds tracked by Wall St. Rank hold CGEN as of Q1 2024.

Clearwater Capital Advisors reported no remaining Compugen position as of Q1 2024 after selling out during the quarter.
Clearwater Capital Advisors sold 11,905 Compugen shares in Q1 2024, an estimated $23.6K.
Clearwater Capital Advisors first reported a position in Compugen in Q4 2021 and held it in 9 quarters.
Clearwater Capital Advisors's Compugen position peaked at $59K in Q4 2021.
73 funds tracked by Wall St. Rank held Compugen as of Q1 2024.

Based on Clearwater Capital Advisors's 13F filing for Q1 2024, filed 9 May 2024.